Gilead Struggles to Recruit Patients for Coronavirus Drug Trial in China

Gilead and health authorities in China are having difficulties recruiting eligible patients into trial of experimental antiviral remdesivir as treatment for Covid-19. Trial aims to test >700 patients with coronavirus, but so far, fewer than 200 people have been recruited.


Biospace Inc.